Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8896 |
High Similarity |
NPD1934 |
Approved |
0.8784 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8726 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8718 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8688 |
High Similarity |
NPD6232 |
Discontinued |
0.8599 |
High Similarity |
NPD1465 |
Phase 2 |
0.8599 |
High Similarity |
NPD2801 |
Approved |
0.858 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.858 |
High Similarity |
NPD6166 |
Phase 2 |
0.858 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD2533 |
Approved |
0.8562 |
High Similarity |
NPD2532 |
Approved |
0.8562 |
High Similarity |
NPD2534 |
Approved |
0.8528 |
High Similarity |
NPD7473 |
Discontinued |
0.8503 |
High Similarity |
NPD230 |
Phase 1 |
0.8491 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8485 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8476 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8443 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8428 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8424 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8424 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8377 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8373 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8291 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8269 |
Intermediate Similarity |
NPD1512 |
Approved |
0.825 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8214 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8214 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.821 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8166 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.816 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8137 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.811 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8105 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8105 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD37 |
Approved |
0.8052 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8037 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8037 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8037 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8036 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8025 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8013 |
Intermediate Similarity |
NPD447 |
Suspended |
0.8012 |
Intermediate Similarity |
NPD5710 |
Approved |
0.8012 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7974 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.795 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7947 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7947 |
Intermediate Similarity |
NPD943 |
Approved |
0.7867 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7866 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7862 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7843 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7841 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7831 |
Intermediate Similarity |
NPD919 |
Approved |
0.7829 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7829 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7806 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7758 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7758 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7753 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7733 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7722 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7673 |
Intermediate Similarity |
NPD6190 |
Approved |
0.767 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7654 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7633 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7616 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD920 |
Approved |
0.7544 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7543 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7531 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7513 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7458 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7458 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7455 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7438 |
Intermediate Similarity |
NPD1243 |
Approved |
0.743 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7389 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7366 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6099 |
Approved |
0.734 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7317 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7288 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7262 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7262 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7256 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7219 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7196 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7196 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7184 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7171 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7165 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD411 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7126 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7107 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7107 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7074 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7073 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7068 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7068 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7068 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7031 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7031 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.701 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7005 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7005 |
Intermediate Similarity |
NPD6534 |
Approved |
0.6993 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD3705 |
Approved |
0.6987 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6977 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6974
|
Remote Similarity |
NPD17 |
Approved |